newsfilter
← Latest News
GlobeNewswire·

Polyrizon Submits Pre-Sub Package to the FDA for PL-14 Allergy Blocker

Ra'anana, Israel, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (NASDAQ:PLRZ) ("Polyrizon" or the "Company"), a biotechnology company focusing on the development of intranasal products, today announced the